MedTrace Logo

Glucocorticoid Induced Whole Body Catabolisme

NCT01762540 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2016-01-08

No results posted yet for this study

Summary

The main purpose of the trial is to advance our knowledge on the possible mechanism underlying the catabolic effects of long-term treatment with glucocorticoid.

Conditions

  • Whole Body Catabolisme Induced by Glucocorticoids

Interventions

DRUG

Glucocorticoids

Prednisolone 37.5 mg x1 for 5 days

DRUG

Calcium Supplement

Placebo

Sponsors & Collaborators

  • The Ministry of Science, Technology and Innovation, Denmark

    collaborator OTHER_GOV

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Jan Frystyk, Professor · Medical Research Laboratory, Clinical institute of Medicine, Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01762540 on ClinicalTrials.gov